Accuray Incorporated
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARAY research report →
Companywww.accuray.com
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.
- CEO
- Stephen R. LaNeve
- IPO
- 2007
- Employees
- 987
- HQ
- Madison, WI, US
Price Chart
Valuation
- Market Cap
- $39.58M
- P/E
- -0.90
- P/S
- 0.09
- P/B
- 0.99
- EV/EBITDA
- -28.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.81%
- Op Margin
- -3.53%
- Net Margin
- -10.76%
- ROE
- -77.48%
- ROIC
- -5.79%
Growth & Income
- Revenue
- $458.50M · 2.68%
- Net Income
- $-1,591,000 · 89.77%
- EPS
- $-0.02 · 90.31%
- Op Income
- $7.84M
- FCF YoY
- 63.48%
Performance & Tape
- 52W High
- $2.10
- 52W Low
- $0.25
- 50D MA
- $0.40
- 200D MA
- $0.97
- Beta
- 1.43
- Avg Volume
- 2.43M
Get TickerSpark's AI analysis on ARAY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | TCW GROUP INC | other | 77,469 |
| Jun 16, 26 | TCW GROUP INC | other | 108,457 |
| Jun 6, 25 | TCW GROUP INC | other | 221,237 |
| Dec 7, 25 | TCW GROUP INC | other | 608,401 |
| Apr 6, 26 | Miele Paul Michael | other | 0 |
| Mar 31, 26 | Chalke Sandeep | other | 40,000 |
| Feb 28, 26 | Peralta Leonel | other | 83,723 |
| Feb 28, 26 | Peralta Leonel | other | 83,723 |
| Feb 28, 26 | Peralta Leonel | other | 28,969 |
| Feb 20, 26 | MAYER STEVEN F | buy | 54,875 |
Our ARAY Coverage
We haven't published any research on ARAY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ARAY Report →